Literature DB >> 33628299

Comparison of the Effects of Essential Oil Obtained from the Crude and Bran-Processed Atractylodes lancea on Lipopolysaccharide-Induced Inflammatory Injury of Human Colonic Epithelial Cells by Downregulating the IKK/NF-κB Signaling Pathway.

Yan Yu1,2, Zhenqi Wu2, Yu Han1, Yuan Yuan1, Hui Fan2, Xinzhi Wei2, Yongduo Yu1,2.   

Abstract

BACKGROUND: Atractylodes lancea (AL) has been used in traditional Chinese medicine for the treatment of various diseases including digestive disorders. Ulcerative colitis (UC) is a common digestive system disease with a low cure rate and easy recurrence. However, it is still not clear whether AL is suitable for UC treatment. Currently, stir-baking with wheat bran is most commonly used to process AL. Here, we aimed to address the effects of the crude and bran-processed AL on UC in vitro and uncover the underlying mechanism based on regulating the IKK/NF-kappa B signaling pathway.
METHODS: Human colonic epithelial cells (HCoEpiC) were treated with lipopolysaccharide (LPS) to mimic the inflammatory injury of UC in vitro. The essential oil from crude and bran-processed AL was used to treat LPS-induced HcoEpiC cells. The cell viability was detected by an MTT assay. The levels of IL-4, IL-6, IL-8, IL-12, IL-1-β, TNF-α, and NO were determined by ELISA, and the mRNA expressions of IKK-α, NF-κB, IL-4, IL-6, IL-8, and TNF-α were determined by RT-PCR. Meanwhile, the expressions of IKK-α, p-IKK-α, p-IKK-β, NF-κB, IL-6, and IL-8 proteins were determined by Western blot.
RESULTS: The essential oil of AL, whether it was from crude or bran-processed AL, could significantly increase the viability of LPS-induced HCoEpiC cells. The treatment of AL essential oil also notably inhibited the productions of IL-6, IL-8, IL-12, IL-1-β, TNF-α, NO, p-IKK-α, p-IKK-β, and NF-κB and downregulated the mRNA expressions of NF-κB, IL-6, IL-8, and TNF-α. Meanwhile, IL-4 protein and mRNA expression were significantly stimulated by AL essential oil. Moreover, the essential oil from bran-processed AL was more effective than that from crude AL.
CONCLUSION: Both kinds of AL essential oil had the anti-inflammatory effect on LPS-induced HCoEpiC, and the essential oil from bran-processed AL was more effective. The mechanism could be through the IKK/NF-κB signaling pathway in vitro.
Copyright © 2021 Yan Yu et al.

Entities:  

Year:  2021        PMID: 33628299      PMCID: PMC7884137          DOI: 10.1155/2021/5219129

Source DB:  PubMed          Journal:  Evid Based Complement Alternat Med        ISSN: 1741-427X            Impact factor:   2.629


  39 in total

1.  β-Sitosterol attenuates high-fat diet-induced intestinal inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB pathway.

Authors:  Kyung-Ah Kim; In-Ah Lee; Wan Gu; Supriya R Hyam; Dong-Hyun Kim
Journal:  Mol Nutr Food Res       Date:  2014-01-09       Impact factor: 5.914

2.  Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.

Authors:  Yu-Xi Yan; Mei-Juan Shao; Qing Qi; Yan-Sheng Xu; Xiao-Qian Yang; Feng-Hua Zhu; Shi-Jun He; Pei-Lan He; Chun-Lan Feng; Yan-Wei Wu; Heng Li; Wei Tang; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

3.  Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis.

Authors:  Weibiao Cao; Matthew D Vrees; Fabio M Potenti; Karen M Harnett; Claudio Fiocchi; Victor E Pricolo
Journal:  J Pharmacol Exp Ther       Date:  2004-06-17       Impact factor: 4.030

4.  The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis.

Authors:  Ping Wu; Yonggao Guo; Fangyuan Jia; Xiuli Wang
Journal:  Cell Biochem Biophys       Date:  2015-05       Impact factor: 2.194

5.  Role of tumor necrosis factor-α and its receptors in diesel exhaust particle-induced pulmonary inflammation.

Authors:  Smitha Kumar; Guy Joos; Louis Boon; Kurt Tournoy; Sharen Provoost; Tania Maes
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

6.  Genetic and environmental factors influencing the contents of essential oil compounds in Atractylodes lancea.

Authors:  Takahiro Tsusaka; Bunsho Makino; Ryo Ohsawa; Hiroshi Ezura
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

7.  Protective effects of oxymatrine against DSS-induced acute intestinal inflammation in mice via blocking the RhoA/ROCK signaling pathway.

Authors:  Yifan Wang; Zhexing Shou; Heng Fan; Meng Xu; Qianyun Chen; Qing Tang; Xingxing Liu; Hui Wu; Man Zhang; Ting Yu; Shuangjiao Deng; Yujin Liu
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

Review 8.  Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivo.

Authors:  Hilda Vargas-Robles; Karla Fabiola Castro-Ochoa; Alí Francisco Citalán-Madrid; Michael Schnoor
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

9.  Comparison of Bran-Processed and Crude Atractylodes Lancea Effects on Spleen Deficiency Syndrome in Rats.

Authors:  Dong-Hua Xue; Yu-Qiang Liu; Qian Cai; Ke Liang; Bing-Yuan Zheng; Fang-Xiao Li; Xue Pang
Journal:  Pharmacogn Mag       Date:  2018-04-10       Impact factor: 1.085

10.  Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation via the IKK/NF-κB pathway in ulcerative colitis.

Authors:  Chang-Wen Yuan; Xue-Liang Sun; Li-Chao Qiao; Hai-Xia Xu; Ping Zhu; Hong-Jin Chen; Bo-Lin Yang
Journal:  World J Gastroenterol       Date:  2019-12-21       Impact factor: 5.742

View more
  2 in total

1.  Network Pharmacology and Molecular Docking Analysis on the Pharmacological Mechanisms of Modified Sanmiaosan in Treating Ulcerative Colitis.

Authors:  Yong Wang; Ying Sun; Ruoran Wang; Jisha Du; Qingqing Wang
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

Review 2.  Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease.

Authors:  Shuo Yuan; You Li; Jiao Li; Jia-Chen Xue; Qi Wang; Xiao-Ting Hou; Huan Meng; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.